DPC Cardiovascular Clinic - Tuesday 29 October 2019
Choose relevant sessions for you in your role:
Multi-disciplinary team – these sessions are suitable for the entire MDT and will aim to promote joint working and understanding of care pathways.
Primary Care & Non-Specialist – designed for healthcare professionals who are not specialists in diabetes or related conditions, and who may work in a Primary Care setting.
Specialist – these sessions are designed for specialists in diabetes and related conditions. Sessions may also be appropriate for Primary Care specialists or leads in diabetes and related conditions.
*NB – These are advisory labels so please read the session description and learning outcomes carefully to ensure the session is right for you
The cost of heart failure
The session will focus on the epidemiology, resource and health service implications of heart failure, particularly in people with type 2 diabetes. In addition this session will evaluate the impact in economic terms of reducing the burden of heart failure hospitalisation. Learning outcomes: Understand the clinical burden of heart failure in type 2 diabetes Gain…
NETWORKING & EXHIBITION
Professional Blinded CGM in Type 1 and Type 2 Patients in the Community and Primary Care Setting
Come along and join this session to learn more about the newest innovation in blinded CGM. Understand how blinded CGM can facilitate in optimal treatment decisions, by providing a comprehensive understanding of glucose profiles to improve health outcomes. Also learn and understand how to use the technology and set up a service in community and…
Vascular Disease screening best practice and service delivery
This session looks at the current recommendations for cardiovascular assessment and screening and opportunities for the future in the NHS Long Term Plan. Learning outcomes: Current Indications for CVS Assessment and opportunities to improve healthcare on a national scale
Thinking beyond HbA1c in Type 2 Diabetes: how can Cardiovascular morbidity and mortality be tackled?
Session sponsored by the Boehringer Ingelheim and Lilly Diabetes Alliance Prescribing and adverse event reporting information is available at: www.jardiancepi.co.uk Boehringer Ingelheim and Lilly Diabetes Alliance products will be discussed at this meeting. The Boehringer Ingelheim and Lilly Diabetes Alliance has provided funding for this sponsored session, including speaker honoraria and presentation development support. Join…
The changing world of diabetes nurse education
This session outlines the rapidly changing world of print and online diabetes nurse education. It highlights the question purchasers of healthcare education should be asking to ensure value for money and quality provision. Current analytics and trends will be outlined to show how print and online education is adapting to meet the demands of nurse…
Overview of Postgraduate Diploma Diabetes Care, University of Warwick
Transforming basal insulin management with JAZZ DoseCoach
The UK’s first basal insulin advisor with integrated blood glucose meter for type 2 patients on once daily basal insulin only, will be available from Autumn 2019. Designed to assist in the self-adjustment of basal insulin dosing, the JAZZ DoseCoach could help tens of thousands of patients who struggle with the complexities of basal insulin…
CVD – Diabetes Prescribing
The T2Day Programme LIVE! at Diabetes Professional Care
Sessions sponsored by the Boehringer Ingelheim and Lilly Diabetes Alliance Prescribing and adverse event reporting information is available at: www.jardiancepi.co.uk Join us for T2Day LIVE! with host Dr Amrit Lamba and our expert guests, clinical psychologist, Dr Jen Bateman and obesity expert and GP, Dr Matt Capehorn as they discuss: How to start the discussion…
CVD risk identification & reduction in Primary Care
Diabetes is associated with an increased risk of developing cardiovascular complications. The complications of diabetes have a high associated cost. The NHS spends £1 in every £10 on diabetes care, and 80p of each £1 is spent on treating the complications of diabetes. However, the cost to the patient is seen in amputations, blindness, end…
